We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Citrus Scent Found to Suppress Liver Cancer

By LabMedica International staff writers
Posted on 28 Jan 2015
Essential oils exist in many plants, protecting them through their antibacterial, antiviral, and fungicidal properties. More...
It has been recently discovered that terpenes, the oils’ chief components, can also suppress the growth of different cancer cells, including liver cancer. Their function had not previously been fully understood.

As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers from the Ruhr-University Bochum (Germany), led by Prof. Dr. Hanns Hatt, have comprehensively studied this process in liver cancer cells. They provide clues into the molecular processes that resulted in cancer cells stop growing, following the application of (-)-citronellal, and they demonstrated that the olfactory receptor OR1A2 is the key molecule for that purpose. In the future, the olfactory receptor could serve as target for liver cancer diagnosis and therapy. The researchers report their findings January 15, 2015, in the journal Archives of Biochemistry and Biophysics.

Terpenes can initiate signaling processes in cells by activating olfactory receptors. Those receptors are mainly located in the nose, but they have been proved to occur in all types of human tissue, including skin, prostate, and spermatozoa. Carcinogenesis and cancer growth are similarly considerably affected by terpenes, even though it has not been understood which function they fulfil.

To determine this, the researchers from Bochum employed a cellular model of hepatocellular carcinoma, a common liver tumor. They exposed the cells to a subset of terpenes with different concentrations, and monitored their reactions. It emerged that two of the 11 terpenes evaluated resulted in a substantial increase in calcium concentration in the cells: (-)-citronellal and citronellol. During a follow-up analysis, the researchers focused on (-)-citronellal and scanned for a receptor into which the terpene has to fit like a key into a lock.

The scientists demonstrated that the decisive olfactory receptor OR1A2 occurs in liver cells and is responsible for detection of the citrus scent and cellular reaction. If the option for producing that receptor had been removed from the cells, they did no longer react to the terpene. The researchers, moreover, succeeded in monitoring the signaling pathway that the terpene uses for increasing calcium concentration inside the cells, thereby decreasing cell growth. “These results are yet another example for the significance of olfactory receptors outside the nose, and they give rise to hope that new drugs with no severe side effects may be developed for cancer therapy,” the authors reported.

The hepatocellular carcinoma is the most common primary tumor of the liver. It is the third most common tumor-induced cause of death.

Related Links:

Ruhr-University Bochum



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.